Trials / Completed
CompletedNCT01999348
A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,553 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study will evaluate patients diagnosed with POAG or OHT who are switched to GANFORT® UD (unit dose of fixed combination bimatoprost and timolol) therapy for medical reasons in accordance with physician standard clinical practice. All treatment decisions lie with the physician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fixed Combination Bimatoprost and Timolol | Patients with POAG or OHT treated with GANFORT® UD (fixed combination bimatoprost and timolol) administered in accordance with physician standard practice for up to 12 weeks. |
Timeline
- Start date
- 2013-11-25
- Primary completion
- 2014-12-19
- Completion
- 2014-12-19
- First posted
- 2013-12-03
- Last updated
- 2019-04-19
- Results posted
- 2015-12-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01999348. Inclusion in this directory is not an endorsement.